Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

Department for Science, Innovation and Technology

Capital grants of £5 million to £25 million for large-scale R&D projects in the UK life sciences sector. Projects must exceed £100 million in total costs and focus on innovation or health resilience with potential economic benefits.

Wer cha sich bewerbe

UK-registered wholly private sector businesses that are product developers, CDMOs, or generics manufacturers, with projects located in the UK, costing at least £100 million total, primarily capital investments, and dependent on the grant to proceed.

Quelle

Links, wo d'KI brucht het zum Informazionä über dë Geldgätter z'sammle.

Finanzierig

£5.0m – £25.0m

Frist

31. März 2028

Startet

25. September 2025

Organisator-Websiiite Quelle aasese

Registriere di für automatisierti Matches mit Geldgätter wie dëter.

Gratis aafange

Berechtigungskriterie

Be a UK-registered and wholly private sector business.
Operate as a product developer, contract development and manufacturing organisation (CDMO), or generics manufacturer.
Provide two years of audited accounts for the applicant company or parent entity. If unavailable, you must demonstrate that the remaining project funding has been secured.
Show a track record of successfully developing or manufacturing medicines or medical devices, either in the UK or internationally.
Your R&D project must have a total cost (including eligible capital and non-capital costs) of at least £100m.
Be located in the UK.
Be primarily a capital investment.
Be a single company investment (as opposed to forming a partnership between companies or other types of organisations).

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

Quelle

Similar grants